Rfg Advisory, LLC Novo Nordisk A S Transaction History

Rfg Advisory, LLC

$3.18 Billion
Q3 2024

A detailed history of Rfg Advisory, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Rfg Advisory, LLC holds 20,328 shares of NVO stock, worth $1.78 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

20,328

Previous 11,123 82.76%

Holding current value

$1.78 Million

Previous $1.59 Million 52.49%

% of portfolio

0.08%

Previous 0.05%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	BUY	$119.07 - $145.42 $1.1 Million - $1.34 Million	9,205 Added 82.76%	20,328 $2.42 Million
Q2 2024 Jul 15, 2024	BUY	$122.71 - $146.91 $46,752 - $55,972	381 Added 3.55%	11,123 $1.59 Million
Q1 2024 Apr 11, 2024	BUY	$102.11 - $135.92 $493,701 - $657,173	4,835 Added 81.85%	10,742 $1.38 Million
Q4 2023 Jan 25, 2024	SELL	$87.78 - $105.45 $99,366 - $119,369	-1,132 Reduced 16.08%	5,907 $611,000
Q3 2023 Oct 16, 2023	BUY	$90.94 - $199.54 $303,375 - $665,665	3,336 Added 90.09%	7,039 $640,000
Q2 2023 Aug 03, 2023	BUY	$155.98 - $172.65 $13,570 - $15,020	87 Added 2.41%	3,703 $599,000
Q1 2023 May 09, 2023	SELL	$132.34 - $159.14 $6,484 - $7,797	-49 Reduced 1.34%	3,616 $575,000
Q4 2022 Feb 14, 2023	SELL	$102.55 - $135.33 $1,640 - $2,165	-16 Reduced 0.43%	3,665 $495,000
Q3 2022 Nov 10, 2022	BUY	$95.28 - $116.93 $8,765 - $10,757	92 Added 2.56%	3,681 $423,000
Q2 2022 Aug 09, 2022	BUY	$103.24 - $121.81 $722 - $852	7 Added 0.2%	3,589 $370,000
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $5,772 - $6,977	62 Added 1.76%	3,582 $398,000
Q4 2021 Feb 02, 2022	SELL	$95.88 - $117.08 $1,438 - $1,756	-15 Reduced 0.42%	3,520 $394,000
Q3 2021 Oct 19, 2021	BUY	$84.42 - $106.62 $928 - $1,172	11 Added 0.31%	3,535 $339,000
Q2 2021 Jul 29, 2021	SELL	$67.66 - $84.76 $4,059 - $5,085	-60 Reduced 1.67%	3,524 $295,000
Q1 2021 Apr 19, 2021	BUY	$67.06 - $75.82 $6,169 - $6,975	92 Added 2.63%	3,584 $242,000
Q4 2020 Feb 02, 2021	SELL	$63.89 - $73.8 $12,778 - $14,760	-200 Reduced 5.42%	3,492 $245,000
Q3 2020 Oct 13, 2020	SELL	$63.69 - $70.22 $3,439 - $3,791	-54 Reduced 1.44%	3,692 $256,000
Q2 2020 Aug 03, 2020	BUY	$58.54 - $67.94 $2,634 - $3,057	45 Added 1.22%	3,746 $245,000
Q1 2020 Apr 17, 2020	SELL	$49.46 - $64.78 $544 - $712	-11 Reduced 0.3%	3,701 $223,000
Q4 2019 Jan 22, 2020	SELL	$49.86 - $58.26 $22,437 - $26,217	-450 Reduced 10.81%	3,712 $215,000
Q3 2019 Nov 13, 2019	SELL	$47.54 - $53.43 $3,280 - $3,686	-69 Reduced 1.63%	4,162 $215,000
Q2 2019 Aug 23, 2019	BUY	$46.79 - $52.47 $197,968 - $222,000	4,231 New	4,231 $216,000

Others Institutions Holding NVO

# of Institutions

1,957

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $197B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rfg Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rfg Advisory, LLC with notifications on news.

Account